The frontline clinicians treating the rapidly growing number of dementia patients see, among other things, a drug industry that has profited handsomely from expensive, marginally effective treatments sought by desperate families.
What I see in different shades of gray, from behind my reading glasses
The frontline clinicians treating the rapidly growing number of dementia patients see, among other things, a drug industry that has profited handsomely from expensive, marginally effective treatments sought by desperate families.